Metraipolis › archive › dc_97a143da2eff

Revitalizing Trimethoprim/Sulfamethoxazole via Nanotechnology for Improved Pharmacokinetics and Antibacterial Efficacy — Europe PMC PMID:41892445

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41892445
DOI: 10.3390/antibiotics15030283
License (as archived): solo-consultazione
Archived: 2026-11-04T21:29:39.031Z
SHA-256 of the archived text: 602546261a0e21d9a71ee0614659a742cebcec04dce880a5ea1d49d1c7948d95
Stable URL of this page: https://metraipolis.com/documento/dc_97a143da2eff

How to cite

Revitalizing Trimethoprim/Sulfamethoxazole via Nanotechnology for Improved Pharmacokinetics and Antibacterial Efficacy — Europe PMC PMID:41892445 — Europe PMC (en), https://europepmc.org/article/MED/41892445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_97a143da2eff (Metraipolis archive dc_97a143da2eff, sha256 602546261a0e21d9a71ee0614659a742cebcec04dce880a5ea1d49d1c7948d95)

BibTeX

@misc{dc97a143da2eff,
  title = {Revitalizing Trimethoprim/Sulfamethoxazole via Nanotechnology for Improved Pharmacokinetics and Antibacterial Efficacy — Europe PMC PMID:41892445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_97a143da2eff; sha256 602546261a0e21d9a71ee0614659a742cebcec04dce880a5ea1d49d1c7948d95},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892445. Agents can read the archived copy with the MCP tool read_document.